SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Warns Shire Pharmaceuticals (JOBS), Eisai Company, Ltd. (JOBS) on Promotions

November 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators have warned Shire PLC (SHP.L) and Eisai Co Ltd (4523.T) about drug promotions that minimized the medicines' risks and overstated benefits, letters released on Friday said.
Clinical research Postmarket research Legal Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
The white plane flies against the blue sky, leaving a white trail. Vector illustration
FDA
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
May 7, 2026
 · 
3 min read
 · 
Heather McKenzie
Big fish eats small, takeover of the company. Art collage.
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
 · 
2 min read
 · 
Gabrielle Masson
3d rendering of a red and silver realistic model of a retro rocket stands crashed into a wooden desk on a blue background. Failed launch. Technological progress. Technical mistake.
Duchenne muscular dystrophy
Entrada crashes as Duchenne therapy comes in ‘below expectations’ in early study
May 7, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman confuse others with jargon in speech bubble dialogue
FDA
Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
May 7, 2026
 · 
4 min read
 · 
Heather McKenzie